Department of Emergency, Fifth Medical Center of Chinese PLA Hospital, Beijing, China.
Department of Blood Transfusion, Fifth Medical Center of Chinese PLA Hospital, Beijing, China.
Clin Hemorheol Microcirc. 2022;80(3):219-231. doi: 10.3233/CH-211113.
This study aimed to explore the clinical detection and prognosis of coagulation function in patients with liver failure and sepsis.
The plasma fibrinogen (FIB), factor II, factor VII, factor V, factor IV, antithrombin III (ATIII), platelet (PLT), mean PLT volume (MPV), D-dimer, prothrombin activity (PTA), and fibrin degradation product (FDP) levels and thromboelastogram values were detected in patients with liver failure complicated with sepsis and compared with those in the liver failure and liver cirrhosis groups. The patients with liver failure complicated with sepsis were analyzed by univariate and multivariate logistic regression, and the regression equation was established.
The levels of FIB, factor II, factor VII, factor V, ATIII, PLT, MPV, D-dimer, and FDP in the patients with liver failure complicated with sepsis were compared with those in the control group patients, and the differences were statistically significant (p < 0.05). Among the thromboelastography parameters in the patients with liver failure and sepsis, the differences in the K-value, R-value, angle, maximum amplitude, and coagulation index values compared with those of the control group were statistically significant (p < 0.05). The logistic regression model obtained was as follows: p = 1/(1 + e [-0.128×X1-0.058×X2 + 0.211×X3 + 0.2×X4 + 0.25]). The specificity, sensitivity, and accuracy values of the regression equation in determining the prognosis were 92%, 93.9%, and 92.8%, respectively. Among the 11 factors, factor VII, PLT, FDP, and D-dimer were included in the regression equation.
Coagulation disorder is exacerbated in patients with liver failure and sepsis. Among the 11 coagulation-related factors, factor VII, PLT, FDP, and D-dimer may be the independent factors influencing the prognosis of patients with acute liver failure and sepsis.
本研究旨在探讨肝功能衰竭合并脓毒症患者凝血功能的临床检测及预后。
检测肝功能衰竭合并脓毒症患者的血浆纤维蛋白原(FIB)、凝血因子Ⅱ、凝血因子Ⅶ、凝血因子Ⅴ、凝血因子Ⅳ、抗凝血酶Ⅲ(ATⅢ)、血小板(PLT)、血小板平均体积(MPV)、D-二聚体、凝血酶原活动度(PTA)、纤维蛋白降解产物(FDP)水平及血栓弹力图值,并与肝功能衰竭组及肝硬化组比较。对肝功能衰竭合并脓毒症患者进行单因素及多因素 logistic 回归分析,建立回归方程。
肝功能衰竭合并脓毒症患者的 FIB、凝血因子Ⅱ、凝血因子Ⅶ、凝血因子Ⅴ、ATⅢ、PLT、MPV、D-二聚体及 FDP 水平与对照组比较,差异均有统计学意义(p<0.05)。肝功能衰竭合并脓毒症患者血栓弹力图参数中 K 值、R 值、角度、最大振幅及凝血指数与对照组比较,差异均有统计学意义(p<0.05)。得到的逻辑回归模型如下:p=1/(1+e[-0.128×X1-0.058×X2+0.211×X3+0.2×X4+0.25])。回归方程对预后的判断特异性、敏感性、准确性分别为 92%、93.9%、92.8%。在 11 个因素中,有因子Ⅶ、PLT、FDP、D-二聚体进入回归方程。
肝功能衰竭合并脓毒症患者凝血功能紊乱加重。在 11 个凝血相关因素中,因子Ⅶ、PLT、FDP、D-二聚体可能是影响急性肝功能衰竭合并脓毒症患者预后的独立因素。